Item 5. Market for Registrant’s Common Equity
ITEM 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
MARKET INFORMATION
At March 31, 2021, our common stock traded on the NASDAQ Global Select Market under the symbol “PLUS.”
On May 20, 2021, there were approximately 150 stockholders of record of our common stock, although there is a much larger number of beneficial owners.
DIVIDEND POLICIES AND RESTRICTIONS
We did not pay any cash dividends on our common stock during the fiscal years ended March 31, 2021, and 2020. Holders of our common stock are entitled to dividends if and when declared by our Board of Directors (“Board”), out of funds legally available. Generally, we have retained our earnings for use in the business. We currently intend to retain future earnings to fund ongoing operations and finance the growth and development of our business. Any future determination concerning the payment of dividends will depend upon our financial condition, results of operations, capital requirements and any other factors deemed relevant by our Board.
PURCHASES OF OUR COMMON STOCK
The following table provides information regarding our total purchases of 96,741 shares of e Plus inc. common stock during the fiscal year ended March 31, 2021, including a total of 59,101 shares purchased as part of the publicly announced share repurchase plans or programs.
Period
Total
number of
shares
purchased
(1)
Average
Price
paid per
share
Total number of
shares
purchased as
part of publicly
announced plans
or programs
Maximum number (or
approximate dollar
value) of shares that
may yet be purchased
under the plans or
programs
April 1, 2020 through April 30, 2020
-
$
-
-
339,324
(2
)
May 1, 2020 through May 27, 2020
996
$
66.75
-
339,324
(3
)
May 28, 2020 through May 31, 2020
-
$
-
-
500,000
(4
)
June 1, 2020 through June 30, 2020
36,644
$
71.94
-
500,000
(5
)
July 1, 2020 through July 31, 2020
-
$
-
-
500,000
(6
)
August 1, 2020 through August 31, 2020
-
$
-
-
500,000
(7
)
September 1, 2020 through September 30, 2020
24,318
$
73.37
24,318
475,682
(8
)
October 1, 2020 through October 31, 2020
25,455
$
70.67
25,455
450,227
(9
)
November 1, 2020 through November 30, 2020
9,328
$
70.99
9,328
440,899
(10
)
December 1, 2020 through December 31, 2020
-
$
-
-
440,899
(11
)
January 1, 2021 through January 31, 2021
-
$
-
-
440,899
(12
)
February 1, 2021 through February 29, 2021
-
$
-
-
440,899
(13
)
March 1, 2021 through March 31, 2021
-
$
-
-
440,899
(14
)
(1)
Any shares acquired were in open-market purchases, except for 37,640 shares, out of which 996 were repurchased in May 2020 and 36,644 in June 2020 to satisfy tax withholding obligations that arose due to the vesting of shares of restricted stock.
(2)
The share purchase authorization in place for the month ended April 30, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of April 30, 2020, the remaining authorized shares to be purchased were 339,324.
(3)
As of May 27, 2020, the authorization under the then existing share repurchase plan expired.
(4)
On May 20, 2020, the board of directors authorized the company to repurchase up to 500,000 shares of our outstanding common stock commencing on May 28, 2020 and continuing to May 27, 2021. As of May 31, 2020, the remaining authorized shares to be purchased were 500,000.
(5)
The share purchase authorization in place for the month ended June 30, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of June 30, 2020, the remaining authorized shares to be purchased were 500,000.
(6)
The share purchase authorization in place for the month ended July 31, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of July 31, 2020, the remaining authorized shares to be purchased were 500,000.
25
Table of Contents
(7)
The share purchase authorization in place for the month ended August 31, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of August 31, 2020, the remaining authorized shares to be purchased were 500,000.
(8)
The share purchase authorization in place for the month ended September 30, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of September 30, 2020, the remaining authorized shares to be purchased were 475,682.
(9)
The share purchase authorization in place for the month ended October 31, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of October 31, 2020, the remaining authorized shares to be purchased were 450,227.
(10)
The share purchase authorization in place for the month ended November 30, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of November 30, 2020, the remaining authorized shares to be purchased were 440,899.
(11)
The share purchase authorization in place for the month ended December 31, 2020, had purchase limitations on the number of shares of up to 500,000 shares. As of December 31, 2020, the remaining authorized shares to be purchased were 440,899.
(12)
The share purchase authorization in place for the month ended January 31, 2021 had purchase limitations on the number of shares of up to 500,000 shares. As of January 31, 2021, the remaining authorized shares to be purchased were 440,899 .
(13)
The share purchase authorization in place for the month ended February 28, 2021 had purchase limitations on the number of shares of up to 500,000 shares. As of February 28, 2021, the remaining authorized shares to be purchased were 440,899 .
(14)
The share purchase authorization in place for the month ended March 31, 2021, had purchase limitations on the number of shares of up to 500,000 shares. As of March 31, 2021, the remaining authorized shares to be purchased were 440,899 .
The timing and expiration date of the share repurchase authorizations are included in Note 12 , “Stockholders’ Equity” to our consolidated financial statements included elsewhere in this report.
ITEM 6.
SELECTED FINANCIAL DATA
Not Applicable
26
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.